CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 19,934	$ 12,346
Marketable debt securities	1,724	3,047
Receivables	7,855	7,685
Inventories	2,384	4,293
Other current assets	2,446	1,983
Total current assets	34,343	29,354
Property, plant and equipment	5,777	6,252
Goodwill	20,578	22,488
Other intangible assets	59,171	63,969
Deferred income taxes	1,088	510
Marketable debt securities	523	767
Other non-current assets	6,596	6,604
Total Assets	128,076	129,944
Current Liabilities:
Short-term debt obligations	4,819	3,346
Accounts payable	2,852	2,445
Other current liabilities	15,750	12,513
Total Current Liabilities	23,421	18,304
Deferred income taxes	6,157	6,454
Long-term debt	41,853	43,387
Other non-current liabilities	7,485	10,101
Total Liabilities	78,916	78,246
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock	0	0
Common stock	292	292
Capital in excess of par value of stock	44,444	43,709
Accumulated other comprehensive loss	(1,556)	(1,520)
Retained earnings	31,565	34,474
Less cost of treasury stock	(25,651)	(25,357)
Total Bristol-Myers Squibb Company Shareholders' Equity	49,094	51,598
Noncontrolling Interest	66	100
Total Equity	49,160	51,698
Total Liabilities and Equity	$ 128,076	$ 129,944